Cargando…

Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core

Detalles Bibliográficos
Autores principales:	Grimm, Juliane, Bhayadia, Raj, Gack, Lucie, Heckl, Dirk, Klusmann, Jan-Henning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252908/ https://www.ncbi.nlm.nih.gov/pubmed/35610347 http://dx.doi.org/10.1038/s41375-022-01603-3

Ejemplares similares

Molecular Mechanisms of the Genetic Predisposition to Acute Megakaryoblastic Leukemia in Infants With Down Syndrome
por: Grimm, Juliane, et al.
Publicado: (2021)

P419: HARNESSING MIRNA-193B-3P MIMIC AS A POTENT THERAPEUTIC OPTION IN ACUTE MYELOID LEUKEMIA
por: Issa, Hasan, et al.
Publicado: (2023)

Preclinical testing of miRNA-193b-3p mimic in acute myeloid leukemias
por: Issa, Hasan, et al.
Publicado: (2023)

P467: LONG NON-CODING RNA SNHG29 IS A NOVEL MYELOID LEUKEMIA DEPENDENCY
por: Winkler, Robert, et al.
Publicado: (2023)

PB1825: IDENTIFYING GENE TARGETS FOR DRUG REPURPOSING TO COUNTER MYELOID LEUKEMIA IN CHILDREN WITH DOWN-SYNDROME (ML-DS)
por: Schmell, Anna-Lena, et al.
Publicado: (2023)

The Regulatory Roles of Long Noncoding RNAs in Acute Myeloid Leukemia
por: Ng, Michelle, et al.
Publicado: (2019)

PB1788: A SCREENING OF DONATED CHEMICAL PROBES TO IDENTIFY NOVEL THERAPEUTIC OPTIONS FOR ACUTE MYELOID LEUKEMIA (AML) IN CHILDHOOD
por: Laszig, Stephanie, et al.
Publicado: (2023)

Long noncoding RNAs as regulators of pediatric acute myeloid leukemia
por: Neyazi, Sina, et al.
Publicado: (2022)

Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus MYNRL15
por: Ng, Michelle, et al.
Publicado: (2023)

PB1813: REGULATORY MECHANISMS AND THERAPEUTIC POTENTIAL OF THE DLK1-DIO3 LOCUS IN PEDIATRIC ACUTE MEGAKARYOBLASTIC LEUKEMIA
por: Verboon, Lonneke, et al.
Publicado: (2023)

RUNX1 isoform disequilibrium promotes the development of trisomy 21–associated myeloid leukemia
por: Gialesaki, Sofia, et al.
Publicado: (2023)

RNA-Binding Proteins in Acute Leukemias
por: Schuschel, Konstantin, et al.
Publicado: (2020)

The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia
por: Moser, Bernhard, et al.
Publicado: (2021)

The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis
por: Alejo-Valle, Oriol, et al.
Publicado: (2022)

JAK-STAT in Early Hematopoiesis and Leukemia
por: Fasouli, Eirini Sofia, et al.
Publicado: (2021)

CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo
por: Reimer, Jana, et al.
Publicado: (2017)

Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia
por: Sharma, Amit, et al.
Publicado: (2020)

Myeloid Leukemia of Down Syndrome
por: Kosmidou, Aikaterini, et al.
Publicado: (2023)

JAK‐STAT core cancer pathway: An integrative cancer interactome analysis
por: Erdogan, Fettah, et al.
Publicado: (2022)

Ritanserin suppresses acute myeloid leukemia by inhibiting DGKα to downregulate phospholipase D and the Jak-Stat/MAPK pathway
por: Tan, Jinshui, et al.
Publicado: (2023)

Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome
por: Raghuram, Nikhil, et al.
Publicado: (2023)

Autolysosomal activation combined with lysosomal destabilization efficiently targets myeloid leukemia cells for cell death
por: Shah, Harshit, et al.
Publicado: (2023)

Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition
por: Abdel-Aziz, Amal Kamal, et al.
Publicado: (2020)

Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells
por: Bulut, Ipek, et al.
Publicado: (2022)

Restoring the Long Noncoding RNA MEG3 Indicates a Potential Role for JAK-STAT Signaling in Chronic Myeloid Leukemia
por: Olson, Thomas L., et al.
Publicado: (2018)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia
por: Alshamleh, Islam, et al.
Publicado: (2023)

Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia
por: Maiques-Diaz, Alba, et al.
Publicado: (2018)

In vitro and in vivo modelling of mutant JAK3/STAT5 signaling in leukemia
por: Omari, Sofia A., et al.
Publicado: (2023)

Potential Role of JAK-STAT Signaling Pathway in the Neurogenic-to-Gliogenic Shift in Down Syndrome Brain
por: Lee, Han-Chung, et al.
Publicado: (2016)

Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT Signalings
por: Zhu, Jian feng, et al.
Publicado: (2011)

The Long Noncoding RNA MEG3 and its Target miR-147 Regulate JAK/STAT Pathway in Advanced Chronic Myeloid Leukemia
por: Li, Zi-ye, et al.
Publicado: (2018)

Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of SHP-1 and Inhibition of JAK/STAT Signaling Pathway
por: Al-Rawashde, Futoon Abedrabbu, et al.
Publicado: (2023)

A JAK/STAT invasion
por: Wells, William A.
Publicado: (2002)

JAK-STAT and bone metabolism
por: Li, Jiliang
Publicado: (2013)

The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)

JAK-STAT in lymphoproliferative disorders
por: Rabadan, Raul, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dmoutev9s5bfb6kf2n4561gqe7